{
    "title": "EU medicines agency recommends approval of Novartis leukaemia drug Rydapt",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-4717818/EU-medicines-agency-recommends-approval-Novartis-leukaemia-drug-Rydapt.html",
    "date": "2017-07-21",
    "keywords": [
        "cancer",
        "drug",
        "portfolio",
        "rydapt",
        "novartis",
        "approval",
        "form",
        "blood",
        "treatment",
        "year",
        "john",
        "july",
        "medicines",
        "agency",
        "panel",
        "drugmaker",
        "oncology",
        "emas",
        "committee",
        "use",
        "chmp",
        "leukaemia",
        "aml",
        "mastocytosis",
        "disease",
        "bodys",
        "mast",
        "opinion",
        "stage",
        "commission",
        "cost",
        "supply",
        "food",
        "administration",
        "expiration",
        "blockbuster",
        "gleevec",
        "seller",
        "sun",
        "bone",
        "marrow",
        "regulator",
        "kisqali",
        "breast",
        "company",
        "blessing",
        "firstofitskind",
        "cell",
        "therapy",
        "ctl019",
        "heart",
        "failure",
        "entresto",
        "psoriasis",
        "cosentyx",
        "growth",
        "reporting",
        "miller",
        "revill",
        "jason"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}